Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Effects of cortisol administration on craving during in vivo exposure in patients with alcohol use disorder.
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4634807
Author(s) Soravia, Leila M; Moggi, Franz; de Quervain, Dominique J-F
Author(s) at UniBasel de Quervain, Dominique
Year 2021
Title Effects of cortisol administration on craving during in vivo exposure in patients with alcohol use disorder.
Journal Translational psychiatry
Volume 11
Number 1
Pages / Article-Number 6
Mesh terms Alcoholism, drug therapy; Craving; Double-Blind Method; Humans; Hydrocortisone; Memory
Abstract

Alcohol-associated memories and craving play a crucial role in the development and maintenance of alcohol use disorder (AUD). As treatment options are limited in AUD, novel treatment strategies focus on the manipulation of alcohol-associated memories. The stress hormone cortisol affects various memory processes, and first clinical studies have shown that it inhibits the retrieval of disorder-specific memories and enhances extinction memory. This study aimed to investigate the effects of a single oral administration of cortisol on craving in patients with AUD during repeated in vivo exposure to alcohol pictures and the preferred alcoholic drink. In a double-blind, block-randomized, placebo-controlled cross-over design, 46 patients with AUD were treated with two sessions of in vivo exposure to alcohol. Cortisol (20 mg) or placebo was orally administered 1 h before each test day. Craving, stress, and cortisol were repeatedly measured during exposure sessions. Results show, that cortisol administration had distinct effects on craving depending on the severity of AUD and test day. While cortisol administration significantly enhanced craving during exposure on the first test day in patients with less severe AUD, it reduced craving in patients with more severe AUD. Independent of the cortisol administration, repeated in vivo exposure reduced craving from test day 1 to test day 2. In conclusion, adding cortisol to in vivo exposure might be a promising approach for reducing the strength of alcohol-associated memories and might promote the consolidation of extinction memory in patients with severe AUD. However, the differential effect of cortisol on craving depending on AUD severity cannot be conclusively explained and highlights the need for future studies elucidating the underlying mechanism.

ISSN/ISBN 2158-3188
Full Text on edoc
Digital Object Identifier DOI 10.1038/s41398-020-01180-y
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/33414435
   

MCSS v5.8 PRO. 0.355 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
28/04/2024